FILTER
FILTERED ARTICLE RESULTS
Funding Environment: Life Sciences Enter the Mainstream
April 20, 2021
The past 12 months been transformative for the life science industry in USA, and GBR explores how the funding environment has evolved to provide the influx of capital to sustain its innovations.
U.S. Pharmaceuticals: The East Coast
July 25, 2019
From New England to the Mid-Atlantic, a rising tide lifts all boats across the biopharma value chain.
Financing Early Stage Drug Candidates Through Their Future Royalties: A New Form of Capital
May 23, 2019
Expert Opinion Article contributed by Jim Neal, CEO of the biotech enterprise XOMA.
Serialization Regulations Put Packaging Into the Limelight
April 24, 2019
Changing serialization requirements represent an opportunity for packaging companies that are looking to add value for their clients.
Breaking Down Drug Pricing
April 01, 2019
The U.S. biopharmaceuticals industry continues to grapple with the perennial issue of drug pricing.
Standing Out in the Biotech Crowd: The VC Investment Climate
February 06, 2019
With biotechs now accounting for 70% of clinical trials in the United States, the VC private investment climate is heating up.
The Indispensable Partner: Contract Services
October 31, 2018
Large Pharma companies often turn to CMOs and CDMOs for specialized expertise, while Biotech startups rely upon their labs and hardware, resulting in a rapidly expanding and increasingly global business.
MACIG
SUBSCRIBE TO OUR NEWSLETTER
RECENTLY PUBLISHED
Italy Lifesciences 2021
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
